| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.33 | 0.02 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.36 | 0.02 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.35 | 0.03 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |